← SynDRA
OXIBENDAZOLE
SynDRA canonical compound SYN0020955 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | TUBB |
|---|
| Mechanism of action | Tubulin inhibitor |
|---|
| Indication | strongyles |
|---|
| Disease area | infectious disease |
|---|
All known targets
Mechanisms of action (all sources)
- microtubule inhibitor
- tubulin polymerization inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ATAD5
- FAAH
- GMNN
- HDAC6
- HIF1A
- LMNA
- MAPK1
- MBNL1
- SAMHD1
- SLCO1B1
- SLCO1B3
- TDP1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- A4
- NR1I2
- VDR
- TP53
- TLR3
- TFE3
- SYK
- STK33
- SMAD3
- SMAD2
- NSD2
- NR1H4
- ANDR
- NF2L2
- MITF
- KSYK
- JAK2
- IFNG
- HTR1E
- GLI3
- GEMI
- ESRRA
- YAP1
Drug classes
- Anthelmintics
- Anti-Infective Agents
- Antiparasitic Agents
Cross-references
Synonyms
- Anthelcide EQ
- NSC-758459
- SK&F-30310
- athelcide eq
- Oxibendazol
- Anthelcide eq
- Filaribits plus
- Oxibendazole, GlaxoSmithKline
- Loditac
- Filaribits Plus
- Oxibendazolo
- Methyl 5-n-propoxy-2-benzimidazole carbamate
- NSC 758459
- 5-Propoxy-2-benzimidazolecarbamic acid methyl ester
- MLS000069646
- 2-BENZIMIDAZOLECARBAMIC ACID, 5-PROPOXY-, METHYL ESTER
- 022N12KJ0X
- MFCD00133728
- NCGC00018238-04
- SMR000058208
- Oxibendazole 100 microg/mL in Acetonitrile
- Oxibendazolum
- Oxibendazolum [INN-Latin]
- Oxibendazolo [INN-Spanish]
- AJ119,(+)
- CAS-20559-55-1
- EINECS 243-877-7
- SKF 30310
- oxybendazole
- UNII-022N12KJ0X
- Oxibendazole [USAN:INN:BAN]
- N-(2-(5-Propoxybenzimidazolyl)) methyl carbamate
- Anthelcide EQ (TN)
- Oxibendazole, ~98%
- Spectrum_001699
- N-(Propoxy-5, benzimidazolyl)-2, carbamate de methyle [French]
- Spectrum2_001556
- Spectrum3_001951
Look up OXIBENDAZOLE in the interactive SynDRA portal →